The Houston Astros’ disappointing trade deadline splash has taken an unbelievable turn following shocking medical updates on outfielder Daulton Varsho. After falling off an offensive cliff following his midseason trade from the Toronto Blue Jays, new reports reveal Varsho was playing through a severe, hidden physical ailment making Toronto’s ability to pull off the deal look like an absolute front-office heist.
Following Houston’s abrupt Wild Card Series exit against the Chicago White Sox, news broke that the 30-year-old outfielder underwent left arthroscopic wrist surgery. Varsho had been placed on the injured list on Sept. 24 due to wrist inflammation, but the real bombshell revealed he had been secretly battling joint-limiting cysts for months, stretching back to his time in Toronto.
The drastic decline in Varsho’s production now makes total sense. Through his first 68 games with the Blue Jays, he was enjoying a career year, batting .266 with a .778 OPS, seven home runs, and 22 RBIs. After joint issues took hold, his numbers cratered. In 41 games with the Astros, Varsho hit a dismal .172 with a .515 OPS, leaving Houston saddled with an injured, non-productive bat when they needed playoff depth the most.
While Toronto clearly managed to offload an ailing asset, their return in the deal hasn’t been smooth sailing either. The Blue Jays acquired pitcher Spencer Arrighetti, who struggled down the stretch with a 6.35 ERA in Toronto while battling his own foot injury (Morton’s neuroma). However, Toronto remains committed to Arrighetti as a long-term rotation piece, hoping he can rediscover the form that earned him AL Pitcher of the Month honors earlier in the season.
For Houston, the revelation adds insult to injury following a painful postseason sweep where Varsho couldn’t even suit up. Trading for a player with an unaddressed, pre-existing joint condition highlights a major evaluation lapse for a franchise accustomed to winning at the deadline.
If Arrighetti recovers and anchors Toronto’s rotation next year, this trade will go down as a masterclass by the Blue Jays and an absolute nightmare for Houston. Space City fans are left asking how their front office missed such a critical medical red flag.
